Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer - BeiGene Australia

Australia
- Australia
- Canada EN|FR
- China
- Germany
- Global
- Spain
- US

⟵ Back to Search Results

Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer

Beigene Study ID

BGB-A317-204

ClinicalTrials.gov ID

NCT04004221

Clinical Drug Trials ID

CTR20170071

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

You will be redirected to

Click the link above to continue or CANCEL